Have a personal or library account? Click to login
Appearance of Clostridium difficile infections in health care institutions in Slovakia and in the district of martin Cover

Appearance of Clostridium difficile infections in health care institutions in Slovakia and in the district of martin

Open Access
|Dec 2018

References

  1. 1. Cohen SH, Gerding DN, Johnson S, Kelly CP, Loo VG, McDonald LC, Pepin J, Wilcox MH; Society for Healthcare Epidemiology of America; Infectious Diseases Society of America. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA). Infect Control and Hosp Epidemiol 2010;31; 431–45510.1086/651706
  2. 2. Zela O, Vítek P. Infekce Clostridium difficile–stav v roce 2012. Medicína pro praxi. 2012: 9 (10): 391-394.
  3. 3. Davies KA, Longshaw CM, Davis GL et al. (2014) Underdiagnosis of Clostridium difficile across Europe: the European, multicentre, prospective, biannual, point-prevalence study of Clostridium Difficile infection in hospitalised patients with diarrhoea (EUCLID). Lancet Infect Dis 14:1208–1219.10.1016/S1473-3099(14)70991-0
  4. 4. McDonald LC, Sievert DM, Gould C. Vital signs: preventing Clostridium difficile infections. Morb Mortal Wkly Rep 2012; 61:157–61.
  5. 5. Slimings C, Armstrong P, Beckingham WD, Bull AL, Hall L, Kennedy KJ, Marquess J, McCann R, Menzies A, Mitchell BG, Richards MJ, Smollen PC, Tracey L, Wilkinson IJ, Wilson FL, Worth LJ, Riley TV. Increasing incidence of Clostridium difficile infection, Australia, 2011–2012. The Med J Aus. 2014; 200 (5): 272-276.10.5694/mja13.11153
  6. 6. Khanna S, Pardi DS, Aronson SL, Kammer PP, Orenstein R, St Sauver JL, Harmsen WS, Zinsmeister AR. The epidemiology of community-acquired Clostridium difficile infection: a population- based study. Am J Gastroenterol 2012; 107: 89 - 95.10.1038/ajg.2011.398
  7. 7. Slimings C, Armstrong P, Beckingham WD, Bull AL, Hall L, Kennedy KJ, Marquess J, McCann R, Menzies A, Mitchell BG, Richards MJ, Smollen PC, Tracey L, Wilkinson IJ, Wilson FL, Worth LJ, Riley TV.Increasing incidence of Clostridium difficile infection, Australia, 2011–2012. The Med J Aus. 2014; 200 (5): 272-276.10.5694/mja13.11153
  8. 8. Viseur N, Lambert M, Delmee M, Van Broeck J, Catry B. Nosocomial and non-nosocomial Clostridium difficile infections in hospitalised patients in Belgium: compulsory surveillance data from 200 8 to 2010. Euro Surveill 2011; 16: 2000010.2807/ese.16.43.20000-en
  9. 9. Lessa FC, Winston LG, McDonald LC; Emerging Infections Program C. difficile Surveillance Team. Burden of Clostridium difficile infection in the United States. N Engl J Med, 2015; 372 (9): 825–834.10.1056/NEJMoa1408913
  10. 10. Ma GK, Brensinger CM, Wu Q, Lewis JD. Increasing incidence of multiply recurrent Clostridium difficile infection in the United States: a cohort study. Ann Intern Med., 2017; 167(3): 152 - 158.10.7326/M16-2733
  11. 11. Clements AC, Magalhães RJ, Tatem AJ, Paterson DL, Riley TV. Clostridium difficile PCR ribotype 027: assessing the risks of further worldwide spread. Lancet Infect Dis 2010; 10: 395-404.10.1016/S1473-3099(10)70080-3
  12. 12. Arvand M1, Vollandt D, Bettge-Weller G, Harmanus C, Kuijper EJ; Clostridium difficile study group Hesse. Increased incidence of Clostridium difficile PCR ribotype 027 in Hesse, Germany. 2011 to 2013. Eurosurveill. 2014; 19(10): 20732.10.2807/1560-7917.ES2014.19.10.20732
  13. 13. Novakova E, Krutova M, Nyc O, Kuijper EJ, Garabasova M, Novak M, Kotlebova N, Stefkovicova S. A high prevalence of Clostridium difficile ribotypes 001 and 176 recognized within an enhanced option of European standardized Clostridium difficile infection surveillance in Slovakia, 2016; 28th ECCMID, Madrid, 2018., Abstract no739.Available from URL: https://www.escmid.org/escmid_publications/-escmid_elibrary/material/?mid=63944 [Accessed 2018 August 9th].(not yet published data)
  14. 14. Stevens V, Dumyati G, Fine LS, Fisher SG, van Wijngaarden E. Cumulative antibiotic exposures over time and the risk of Clostridium difficile infection. Clin Infect Dis. 2011;53(1):42-48.10.1093/cid/cir30121653301
  15. 15. Slimings C, Riley TV. Antibiotics and hospital-acquired Clostridium difficile infection: update of systematic review and meta-analysis. J Antimicrob Chemother. 2014;69(4):881-891.10.1093/jac/dkt47724324224
  16. 16. Brown K, Valenta K, Fisman D, Simor A, Daneman N. Hospital ward antibiotic prescribing and the risks of Clostridium difficile infection. JAMA Intern Med, 2015; 175 (4): 626-633.10.1001/jamainternmed.2014.827325705994
  17. 17. Chitnis AS, Holzbauer SM, Belflower RM, et al. Epidemiology of Community-Associated Clos - tridium difficile Infection, 2009 Through 2011. JAMA Intern Med. 2013; 173 (14):1359–1367.10.1001/jamainternmed.2013.705623780507
  18. 18. Loo VG, Bourgault AM, Poirier L, Lamothe F, Michaud S, Turgeon N, Toye B, Beaudoin A, Frost EH, Gilca R, Brassard P, Dendukuri N, Béliveau C, Oughton M, Brukner I, Dascal A.Host and pathogen factors for Clostridium difficile infection and colonization. N Engl J Med. 2011 Nov 3; 365 (18): 1693-703.10.1056/NEJMoa101241322047560
DOI: https://doi.org/10.2478/acm-2018-0007 | Journal eISSN: 1338-4139 | Journal ISSN: 1335-8421
Language: English
Page range: 5 - 12
Submitted on: Aug 16, 2018
|
Accepted on: Nov 5, 2018
|
Published on: Dec 7, 2018
Published by: Sciendo
In partnership with: Paradigm Publishing Services
Publication frequency: 3 issues per year

© 2018 M Novak, I Mazakova, V Sadlonova, T Cervenova, H. Hudeckova, published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.